ANEB
Anebulo Pharmaceuticals (ANEB)
$50
About Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Details
Daily high
$0.66
Daily low
$0.44
Price at open
$0.44
52 Week High
$3.42
52 Week Low
$0.44
Market cap
33.7M
Dividend yield
0.00%
Volume
793,187
Avg. volume
66,970
P/E ratio
-3.49
Anebulo Pharmaceuticals News
Details
Daily high
$0.66
Daily low
$0.44
Price at open
$0.44
52 Week High
$3.42
52 Week Low
$0.44
Market cap
33.7M
Dividend yield
0.00%
Volume
793,187
Avg. volume
66,970
P/E ratio
-3.49